NDUFB8
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial
Also known as: ASHI, CI-ASHI, NDUB8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95169
- Gene
- NDUFB8
- Ensembl
- ENSG00000166136
- Chromosome
- 10
- Canonical length
- 186 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Predicted to enable NADH dehydrogenase (ubiquinone) activity. Predicted to be involved in mitochondrial electron transport, NADH to ubiquinone and proton motive force-driven mitochondrial ATP synthesis. Located in mitochondrial inner membrane. Part of respiratory chain complex I. Implicated in nuclear type mitochondrial complex I deficiency 32. Biomarker of Alzheimer's disease and Parkinson's disease. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
186 residues, UniProt reviewed canonical sequence.
>O95169|NDUFB8
1 MAVARAGVLG VQWLQRASRN VMPLGARTAS HMTKDMFPGP YPRTPEERAA AAKKYNMRVE
61 DYEPYPDDGM GYGDYPKLPD RSQHERDPWY SWDQPGLRLN WGEPMHWHLD MYNRNRVDTS
121 PTPVSWHVMC MQLFGFLAFM IFMCWVGDVY PVYQPVGPKQ YPYNNLYLER GGDPSKEPER
181 VVHYEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NDUFB8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 563 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 563 nTPM
- amygdala: 532 nTPM
- tongue: 478 nTPM
- heart muscle: 456 nTPM
- hippocampal formation: 426 nTPM
- choroid plexus: 412 nTPM
Single-cell type
- parietal cells: 647 nCPM
- enterocytes: 412 nCPM
- hofbauer cells: 387 nCPM
- esophageal suprabasal cells: 366 nCPM
- enteric transient amplifying cells: 342 nCPM
- colonocytes: 328 nCPM
Immune cell
- total PBMC: 1,115 nTPM
- T-reg: 820 nTPM
- plasmacytoid DC: 657 nTPM
- memory B-cell: 619 nTPM
- myeloid DC: 591 nTPM
- intermediate monocyte: 560 nTPM
Brain region
- cerebral cortex: 265 nTPM
- thalamus: 218 nTPM
- white matter: 218 nTPM
- hypothalamus: 213 nTPM
- pons: 210 nTPM
- midbrain: 209 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NDUFB8.
Disease | AllUniProt
Conditions NDUFB8 is implicated in, by any mechanism.
- Mitochondrial complex I deficiency, nuclear type 32 (MC1DN32) MIM:618252
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 107 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial complex I deficiency, nuclear type 32
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.11
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial electron transport, NADH to ubiquinone
- proton motive force-driven mitochondrial ATP synthesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8
- NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, metazoa
- NADH-ubiquinone oxidoreductase ASHI subunit (CI-ASHI or NDUFB8)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NDUFB8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NDUFB8 as an antibody target. Whether an autoantibody or antibody against NDUFB8 could matter depends on whether native NDUFB8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NDUFB8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NDUFB8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...